Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07241013 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Tissue-Engineered Construct Based on Amniotic Membrane and Calcium Alginate for Cesarean Section Wound Healing

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This clinical trial aims to evaluate the safety and efficacy of an experimental tissue-engineered construct (TEC) based on amniotic membrane and calcium alginate for promoting epithelialization and improving scar quality in patients after cesarean section. The study will assess both biological and clinical indicators of wound healing, including cytokine dynamics (IL-6, IL-10), ultrasound characteristics, and patient-reported outcomes.
Trial Details
NCT Number NCT07241013
Lead Sponsor Asfendiyarov Kazakh National Medical University
Collaborators: Center for Perinatology and Pediatric Surgery, Almaty, Kazakhstan, Zhalyn Scientific and Technical Production Center, Almaty, Kazakhstan
Conditions
(from sponsor)		 Skin Wound Healing After Cesarean Section, Cesarean Section Scar Healing
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov